Evidence map›Paper›PMID 34500740›Full record

ArticleMolecules (Basel, Switzerland)2021

Conjugated β-Cyclodextrin Enhances the Affinity of Folic Acid towards FRα: Molecular Dynamics Study.

Mohammad G Al-Thiabat, Amirah Mohd Gazzali, Noratiqah Mohtar, Vikneswaran Murugaiyah, Ezatul Ezleen Kamarulzaman, Beow Keat Yap, Noorsaadah Abd Rahman, Rozana Othman, Habibah A Wahab

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 26 citations in OpenAlex.

  1. Antiplasmodial Compounds fromInternational journal of molecular sciences · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Investigating small molecule compounds targeting psoriasis based on cMAP database and molecular dynamics simulation.Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Mohammad G Al-ThiabatSchool of Pharmaceutical Sciences, Universiti Sains Malaysia, George Town 11800, Malaysia.
Amirah Mohd GazzaliSchool of Pharmaceutical Sciences, Universiti Sains Malaysia, George Town 11800, Malaysia.ORCID 0000-0003-4469-1969
Noratiqah MohtarSchool of Pharmaceutical Sciences, Universiti Sains Malaysia, George Town 11800, Malaysia.ORCID 0000-0002-7040-2158
Vikneswaran MurugaiyahSchool of Pharmaceutical Sciences, Universiti Sains Malaysia, George Town 11800, Malaysia.
Ezatul Ezleen KamarulzamanSchool of Pharmaceutical Sciences, Universiti Sains Malaysia, George Town 11800, Malaysia.
Beow Keat YapSchool of Pharmaceutical Sciences, Universiti Sains Malaysia, George Town 11800, Malaysia.ORCID 0000-0003-2156-7682
Noorsaadah Abd RahmanDepartment of Chemistry, Faculty of Science, Universiti Malaya, Kuala Lumpur 50603, Malaysia.
Rozana OthmanCenter for Natural Products Research and Drug Discovery (CENAR), Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Universiti Malaya, Kuala Lumpur 50603, Malaysia.ORCID 0000-0002-8260-9252
Habibah A WahabSchool of Pharmaceutical Sciences, Universiti Sains Malaysia, George Town 11800, Malaysia.ORCID 0000-0002-8353-8679
Universiti Sains Malaysia · MYUniversity of Malaya · MY

Funding

Ministry of Higher Education, Malaysia RU029-2014/5526306)Universiti Malaya RU029-2014/5526306
6 · The paper itself

Abstract

Drug targeting is a progressive area of research with folate receptor alpha (FRα) receiving significant attention as a biological marker in cancer drug delivery. The binding affinity of folic acid (FA) to the FRα active site provides a basis for recognition of FRα. In this study, FA was conjugated to beta-cyclodextrin (βCD) and subjected to in silico analysis (molecular docking and molecular dynamics (MD) simulation (100 ns)) to investigate the affinity and stability for the conjugated system compared to unconjugated and apo systems (ligand free). Docking studies revealed that the conjugated FA bound into the active site of FRα with a docking score (free binding energy < -15 kcal/mol), with a similar binding pose to that of unconjugated FA. Subsequent analyses from molecular dynamics (MD) simulations, root mean square deviation (RMSD), root mean square fluctuation (RMSF), and radius of gyration (Rg) demonstrated that FA and FA-βCDs created more dynamically stable systems with FRα than the apo-FRα system. All systems reached equilibrium with stable RMSD values ranging from 1.9-2.4 Å and the average residual fluctuation values of the FRα backbone atoms for all residues (except for terminal residues ARG8, THR9, THR214, and LEU215) were less than 2.1 Å with a consistent Rg value of around 16.8 Å throughout the MD simulation time (0-100 ns). The conjugation with βCD improved the stability and decreased the mobility of all the residues (except residues 149-151) compared to FA-FRα and apo-FRα systems. Further analysis of H-bonds, binding free energy (MM-PBSA), and per residue decomposition energy revealed that besides APS81, residues HIS20, TRP102, HIS135, TRP138, TRP140, and TRP171 were shown to have more favourable energy contributions in the holo systems than in the apo-FRα system, and these residues might have a direct role in increasing the stability of holo systems.

Indexed as

beta-CyclodextrinsFolate Receptor 1Folic AcidMolecular Dynamics SimulationProtein Bindingbeta-CyclodextrinsFolate Receptor 1Folic Acidfolate receptor alphafolic acid-conjugated cyclodextrinsH-bondsMM-PBSAMM-PBSA per residue energy decompositionmolecular dockingmolecular dynamicsradius of gyration (Rg)targeted drug delivery system

Identifiers

PMID34500740
PMCPMC8434473
OpenAlexW3196580622

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.